日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial

辅助性纳武利尤单抗和瑞拉利单抗治疗 III/IV 期黑色素瘤:随机 3 期 RELATIVITY-098 试验

Long, Georgina V; Garnett-Benson, Charlie; Dolfi, Sonia; Ascierto, Paolo A; Guo, Jun; Tarhini, Ahmad A; Chandra, Sunandana; Muñoz-Couselo, Eva; Del Vecchio, Michele; de Melo, Andreia Cristina; Callahan, Margaret; Gogas, Helen; Dummer, Reinhard; Schadendorf, Dirk; Koelblinger, Peter; Quereux, Gaelle; Thomas, Ioannis; Yu, Jia Xin; Fisher, Andrew; Wang, Bonnie; Djidel, Patrick; Chouzy, Armand; Semaan, Mark; Chen, Bohang; Cheong, Alicia M Y; Tawbi, Hussein A

Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis

免疫检查点抑制剂诱导的黑色素瘤患者胰酶升高:发生率、管理和治疗——一项多中心分析

Brandlmaier, M; Hoellwerth, M; Silly, T; Hoeller, C; Koch, L; Richtig, E; Binder, K; Lange-Asschenfeldt, B; Barta, M; Schmid-Simbeck, M; Froehlich, F; Dummer, R; Muigg, L; Hitzl, W; Koelblinger, P

Eyelid nodule with persistent growth

眼睑结节持续生长

Hoellwerth, Magdalena; Brandlmaier, Matthias; Selhofer, Sylvia; Laimer, Martin; Koelblinger, Peter

Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation

早期皮肤黑色素瘤的辅助性PD-1检查点抑制:免疫作用机制及紫外线辐射的作用

Brandlmaier, Matthias; Hoellwerth, Magdalena; Koelblinger, Peter; Lang, Roland; Harrer, Andrea

Beyond T cell toxicity - Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review

超越T细胞毒性——鞘内趋化因子CXCL13提示B细胞参与免疫检查点抑制剂治疗后的免疫相关不良事件:两例病例系列及文献综述

Otto, Ferdinand; Seiberl, Michael; Bieler, Lara; Moser, Tobias; Kleindienst, Waltraud; Wallner-Essl, Walter; Koelblinger, Peter; Wipfler, Peter; Harrer, Andrea

Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial

达拉非尼联合曲美替尼治疗未经筛选的晚期 BRAF V600 突变型黑色素瘤:一项非干预性、多中心、前瞻性试验

Richtig, Erika; Nguyen, Van A; Koelblinger, Peter; Wolf, Ingrid; Kehrer, Helmut; Saxinger, Werner; Ressler, Julia M; Weinlich, Georg; Meyersburg, Damian; Hafner, Christine; Jecel-Grill, Elisabeth; Kofler, Julian; Lange-Asschenfeldt, Bernhard; Weihsengruber, Felix; Rappersberger, Klemens; Svastics, Nina; Gasser, Klaus; Seeber, Arno; Kratochvill, Franz; Nagler, Sophie; Mraz, Bernhard; Hoeller, Christoph

Predictive value and accuracy of [(18)F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma

[(18)F]FDG PET/CT 改良的免疫检查点疗法疗效评价标准在晚期黑色素瘤患者中的预测价值和准确性

Ayati, Narjess; Jamshidi-Araghi, Zahra; Hoellwerth, Magdalena; Schweighofer-Zwink, Gregor; Hitzl, Wolfgang; Koelblinger, Peter; Pirich, Christian; Beheshti, Mohsen

Prognostic Value of Baseline (18)F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients

基线(18)F-FDG PET/CT对预测黑色素瘤患者脑转移发生的预后价值

Kalantari, Forough; Mirshahvalad, Seyed Ali; Hoellwerth, Magdalena; Schweighofer-Zwink, Gregor; Huber-Schönauer, Ursula; Hitzl, Wolfgang; Rendl, Gundula; Koelblinger, Peter; Pirich, Christian; Beheshti, Mohsen

Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research

重新审视CXCL13/CXCR5相关免疫轴在黑色素瘤中的作用:对PD-1相关生物标志物研究的潜在意义

Hoellwerth, Magdalena; Koelblinger, Peter; Lang, Roland; Harrer, Andrea

Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity

无论肿瘤遗传学和代谢可塑性如何,生酮饮食都能减缓体内黑色素瘤的生长

Daniela D Weber #, Sepideh Aminzadeh-Gohari #, Maheshwor Thapa, Anna-Sophia Redtenbacher, Luca Catalano, Tânia Capelôa, Thibaut Vazeille, Michael Emberger, Thomas K Felder, René G Feichtinger, Peter Koelblinger, Guido Dallmann, Pierre Sonveaux, Roland Lang, Barbara Kofler